在患有囊性纤维化的成年人中，初次肺部加重期急性治疗期间体重增加与距离下次加重的间隔时间延长有关。
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.
作者信息
Barr Helen L, Cámara Miguel, Barrett David, Williams Paul, Forrester Doug, Smyth Alan, Honeybourne David, Whitehouse Joanna, Nash Edward, Dewar Jane, Knox Alan, Fogarty Andrew W
机构信息
Division of Respiratory Medicine, University of Nottingham, Nottingham, UK.
Centre for Biomolecular Sciences, School of Life Sciences, University of Nottingham, Nottingham, UK.
出版信息
ERJ Open Res. 2017 Aug 25;3(3). doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul.
相似文献
1
Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis.在患有囊性纤维化的成年人中，初次肺部加重期急性治疗期间体重增加与距离下次加重的间隔时间延长有关。
ERJ Open Res. 2017 Aug 25;3(3). doi: 10.1183/23120541.00057-2017. eCollection 2017 Jul.
2
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.用于囊性纤维化患者肺部加重期的静脉用抗生素
Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3.
3
Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis.囊性纤维化患者的巨细胞病毒相关性肺部病情加重
ERJ Open Res. 2018 Jan 10;4(1). doi: 10.1183/23120541.00111-2017. eCollection 2018 Jan.
4
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.家用电子症状和肺功能监测以检测囊性纤维化肺部恶化的随机试验的原理和设计：囊性纤维化恶化早期干预（eICE）试验。
Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19.
5
Antibiotic duration and changes in FEV are not associated with time until next exacerbation in adult cystic fibrosis: a single center study.抗生素疗程和 FEV 变化与成人囊性纤维化下一次加重的时间无关：一项单中心研究。
BMC Pulm Med. 2017 Nov 29;17(1):160. doi: 10.1186/s12890-017-0503-6.
6
The Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC) trial: Rationale and design of a multi-center, double-blind, placebo-controlled trial of high dose bolus administration of vitamin D3 during acute pulmonary exacerbation of cystic fibrosis.囊性纤维化增强免疫系统维生素D（DISC）试验：在囊性纤维化急性肺部加重期大剂量推注维生素D3的多中心、双盲、安慰剂对照试验的原理与设计
Contemp Clin Trials Commun. 2017 Jun;6:39-45. doi: 10.1016/j.conctc.2017.02.010. Epub 2017 Mar 9.
7
Vitamin D for the Immune System in Cystic Fibrosis (DISC): a double-blind, multicenter, randomized, placebo-controlled clinical trial.囊性纤维化（DISC）免疫中维生素 D 作用：一项双盲、多中心、随机、安慰剂对照临床试验。
Am J Clin Nutr. 2019 Mar 1;109(3):544-553. doi: 10.1093/ajcn/nqy291.
8
Therapeutic drug monitoring in cystic fibrosis and associations with pulmonary exacerbations and lung function.囊性纤维化中的治疗药物监测及其与肺部加重和肺功能的关联。
Respir Med. 2023 Jun;212:107237. doi: 10.1016/j.rmed.2023.107237. Epub 2023 Apr 6.
9
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.肺动脉增大与囊性纤维化肺部恶化：一项队列研究。
Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10.
10
Antibiotic Therapy for Pulmonary Exacerbations in Cystic Fibrosis-A Single-Centre Prospective Observational Study.囊性纤维化肺部加重期的抗生素治疗——一项单中心前瞻性观察研究
Antibiotics (Basel). 2023 Apr 9;12(4):734. doi: 10.3390/antibiotics12040734.
本文引用的文献
1
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis.铜绿假单胞菌群体感应分子与囊性纤维化的临床状况相关。
Eur Respir J. 2015 Oct;46(4):1046-54. doi: 10.1183/09031936.00225214. Epub 2015 May 28.
2
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.囊性纤维化患者肺部加重期治疗的短期和长期反应
Thorax. 2016 Mar;71(3):223-9. doi: 10.1136/thoraxjnl-2014-206750. Epub 2015 Apr 24.
3
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines.欧洲囊性纤维化协会护理标准：最佳实践指南。
J Cyst Fibros. 2014 May;13 Suppl 1:S23-42. doi: 10.1016/j.jcf.2014.03.010.
4
Accelerating the rate of improvement in cystic fibrosis care: contributions and insights of the learning and leadership collaborative.加速囊性纤维化护理的改善速度：学习和领导力协作的贡献和见解。
BMJ Qual Saf. 2014 Apr;23 Suppl 1:i23-i32. doi: 10.1136/bmjqs-2014-002804.
5
The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.囊性纤维化基金会患者登记处作为质量改进的工具。
BMJ Qual Saf. 2014 Apr;23 Suppl 1:i9-14. doi: 10.1136/bmjqs-2013-002378. Epub 2014 Jan 17.
6
Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.体型测量指标与囊性纤维化成人的肺功能相关：一项基于人群的研究。
J Cyst Fibros. 2013 May;12(3):284-9. doi: 10.1016/j.jcf.2012.08.008. Epub 2012 Sep 5.
7
Are measures of body habitus associated with mortality in cystic fibrosis?体型测量指标与囊性纤维化患者的死亡率有关吗？
Chest. 2012 Sep;142(3):712-717. doi: 10.1378/chest.11-2124.
8
Nutritional management of cystic fibrosis.囊性纤维化的营养管理。
JPEN J Parenter Enteral Nutr. 2012 Jan;36(1 Suppl):60S-7S. doi: 10.1177/0148607111420156.
9
Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis.在成人和儿童囊性纤维化患者中，肺部恶化与随后的 FEV1 下降有关。
Pediatr Pulmonol. 2011 Apr;46(4):393-400. doi: 10.1002/ppul.21374. Epub 2010 Oct 21.
10
Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.反复加重影响成年囊性纤维化患者的第一秒用力呼气容积（FEV₁）下降。
Respir Med. 2009 Mar;103(3):407-13. doi: 10.1016/j.rmed.2008.09.024. Epub 2008 Nov 22.
Zotero 插件